Steve Tutton
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Steve Tutton has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Andrew V. Kossenkov
The Wistar Institute, Philadelphia, Pennsylvania
1 shared publication Fang Lu
The Wistar Institute, Program in Gene Expression and Regulation, Philadelphia, Pennsylvania, United States of America
1 shared publication- Joseph M. Salvino
The Wistar Institute, Philadelphia, USA
1 shared publication Kayla A. Martin
The Wistar Institute, Program in Gene Expression and Regulation, Philadelphia, Pennsylvania, United States of America
1 shared publication- Nadezhda Tikhmyanova
The Wistar Institute, Program in Gene Expression and Regulation, Philadelphia, Pennsylvania, United States of America
1 shared publication - Nicholas Paparoidamis
Drexel University, College of Medicine, Department of Pharmacology, Philadelphia, Pennsylvania, United States of America
1 shared publication
Latest Publications
- Open Access
- 17 July 2017
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 13 (7) , e1006517
Small molecule perturbation of the CAND1-Cullin1-ubiquitin cycle stabilizes p53 and triggers Epstein-Barr virus reactivation
The chemical probe C60 efficiently triggers Epstein-Barr Virus (EBV) reactivation from latency through an unknown mechanism. Here, we identify the Cullin exchange factor CAND1 as a biochemical target of C60. We also identified CAND1 in an shRNA library screen for EBV lytic reactivation. Gene expression profiling revealed that C60 activates the p53 pathway and protein analysis revealed a strong stabilization and S15 phosphorylation of p53. C60 reduced Cullin1 association with CAND1 and led to a global accumulation of ubiquitylated substrates. C60 also stabilized the EBV immediate early protein ZTA through a Cullin-CAND1-interaction motif in the ZTA transcription activation domain. We propose that C60 perturbs the normal interaction and function of CAND1 with Cullins to promote the stabilization of substrates like ZTA and p53, leading to EBV reactivation from latency. Understanding the mechanism of action of C60 may provide new approaches for treatment of EBV associated tumors, as well as new tools to stabilize p53.
- 17 July 2017
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 13 (7) , e1006517
Open AccessSmall molecule perturbation of the CAND1-Cullin1-ubiquitin cycle stabilizes p53 and triggers Epstein-Barr virus reactivation
The chemical probe C60 efficiently triggers Epstein-Barr Virus (EBV) reactivation from latency through an unknown mechanism. Here, we identify the Cullin exchange factor CAND1 as a biochemical target of C60. We also identified CAND1 in an shRNA library screen for EBV lytic reactivation. Gene expression profiling revealed that C60 activates the p53 pathway and protein analysis revealed a strong stabilization and S15 phosphorylation of p53. C60 reduced Cullin1 association with CAND1 and led to a global accumulation of ubiquitylated substrates. C60 also stabilized the EBV immediate early protein ZTA through a Cullin-CAND1-interaction motif in the ZTA transcription activation domain. We propose that C60 perturbs the normal interaction and function of CAND1 with Cullins to promote the stabilization of substrates like ZTA and p53, leading to EBV reactivation from latency. Understanding the mechanism of action of C60 may provide new approaches for treatment of EBV associated tumors, as well as new tools to stabilize p53.